During the past decade, Nevada Access to Research and Education Society conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nevada Access to Research and Education Society" are "Hereditary Angioedema" (3 trials) and "Hereditary Angioedema (HAE)" (3 trials). Many other conditions were trialed in "Nevada Access to Research and Education Society" in a lesser frequency.

Most popular intervention types in "Nevada Access to Research and Education Society" are "Biological" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "C1 esterase inhibitor [human] (C1INH-nf)" (3 trials), "ecallantide" (2 trials), "CINRYZE 1000" (1 trials), "CINRYZE 500" (1 trials) and "Phosphate Buffer Saline (PBS), pH 7.0" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nevada Access to Research and Education Society" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nevada Access to Research and Education Society". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nevada Access to Research and Education Society, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nevada Access to Research and Education Society, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".